Showing results (971-980 of 1,436) with videos related to
Sort By:
Pageof 144
Experimental Dermatology|September 20, 2024
Biodistribution of iron oxide tattoo pigment: An experimental murine studyKasper Køhler Alsing, Helle Hjorth Johannesen, Rasmus Hvass Hansen, et al.Annals of the Rheumatic Diseases|November 12, 2015
Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS)Anna Sällfors Holmqvist, Jørgen H Olsen, Lene Mellemkjaer, et al.Nuclear Medicine and Biology|March 19, 2004
New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkeyThomas Balle, Christer Halldin, Linus Andersen, et al.ACS Chemical Neuroscience|January 24, 2019
Amyloid-β Peptide Targeting Peptidomimetics for Prevention of NeurotoxicityDmytro Honcharenko, Alok Juneja, Firoz Roshan, et al.Journal of Medicinal Chemistry|January 1, 1988
N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonistsL E Arvidsson, A M Johansson, U Hacksell, et al.International Journal of Cancer|March 27, 2024
Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme studyAlberte Hjorth Duus, Charlotte Gerd Hannibal, Louise Baandrup, et al.The Journal of Steroid Biochemistry and Molecular Biology|June 28, 2026
The 24,25(OH)2D3-TLCD3B signaling complex and reproductive function in mice and menIreen Kooij, Katrine Mitrofanov, Anders Rehfeld, et al.Journal of Medicinal Chemistry|November 1, 1987
(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonistL E Arvidsson, A M Johansson, U Hacksell, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2020
COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospitalHåkon Ihle-Hansen, Trygve Berge, Anders Tveita, et al.Vaccine|September 19, 2025
Assessment of critical bioprocess parameters for broadly cross-reactive chimeric hemagglutinin influenza virus vaccinesMichael J Scherm, Robert Hölzl, Irene González-Domínguez, et al.Pageof 144